# Project State Continuation

Created: 2026-06-04  
Updated: 2026-06-09

Repository: `fyz1500wr/pharma-regulatory-clinical-intelligence-mcp`

This file is a compact continuation handoff for starting a new chat.

Canonical detailed status is in `.ai/PROJECT_STATE.md`. This file is the preferred short handoff when chat context becomes slow or too long.

## Current checkpoint

- Stable branch: `main`
- Latest confirmed merged PR: PR #111
- PR #111 merge commit: `605b2dc819852a90874ee8016ec64c37f87e5e7b`
- Latest completed workstream: CMC submission readiness docs/spec workflow through mapping workflow, mock inventory, input template / prompt pack, management summary prompt revision, and second mock management weekly reporting stress test
- Latest validation status: `PASS`
- Latest validation evidence from Claude Code on PR #111 branch `revise-cmc-readiness-management-summary-prompt` at HEAD `2dce4d1`:
  - `python -m pytest tests/test_readme_documentation_index.py -q` → `10 passed in 0.02s`
  - `python -m pytest -q` → `212 passed in 2.89s`
  - `git status --short` → clean / no output
- Second Claude Project stress test after PR #111: `PASS`
- Second stress-test repository action recommendation: `No repo change needed`
- Current decision: do not create `docs/cmc_management_weekly_report_template.md` at this time
- Current tagged release: remains `v0.2.15-fda-abuse-detection-source-failure-diagnostics`; no new release tag was created for PR #97–#111 docs/product workflow work
- Duplicate PR handling: PR #108 and PR #109 were closed as superseded because their README-index wording change was absorbed into PR #107
- Open PRs at this checkpoint: none known after PR #111 merge
- Execution environment note: Codespaces quota is near limit until July 2026. For upcoming code/test work, default to Claude Code Web and Codex Web workflows. Do not assume Codespaces is available unless the user explicitly says it is available again.

## Current project phase

The project is still MVP v1 and must remain source- and scope-controlled.

Approved MVP source scope remains:

```text
FDA
TFDA
ClinicalTrials.gov
```

Do not add EMA, PMDA, NMPA, CTIS, WHO ICTRP, literature, patent, finance, news, company-alias database, corporate-family mapping, product ownership inference, dashboard, scheduler, alerting, persistence, HTTP/SSE transport, `.mcp.json`, GitHub automation, or other integrations unless explicitly approved.

The repository is not a GMP, QA, EDMS, eCTD publishing, official submission, clinical decision support, legal decision, medical decision, commercial intelligence, or management decision system. Do not store confidential, signed, GMP raw, QA-approved, official submission, vendor confidential, or non-public company records in this repo.

## Recent relevant PR sequence

### PR #97–#103 — Regulatory-clinical digest/report docs-spec workstream

Completed a controlled PM/RA digest/report documentation workstream:

```text
docs/regulatory_clinical_digest_report_workflow.md
docs/regulatory_clinical_digest_example_memo.md
docs/regulatory_clinical_digest_prompt_pack.md
docs/regulatory_clinical_digest_memo_validation_exercise.md
docs/regulatory_clinical_digest_report_template_contract.md
docs/regulatory_clinical_digest_clean_source_dry_run.md
```

Purpose:

- Define how MVP tool outputs should be turned into PM/RA-facing regulatory-clinical intelligence memo drafts.
- Preserve source coverage caveats and sponsor/company association caveats.
- Keep reporting docs/spec-only and avoid runtime report generator work without explicit approval.

### PR #104 — CMC submission readiness mapping workflow

Added:

```text
docs/cmc_submission_readiness_mapping_workflow.md
```

Purpose:

- Define a docs/spec-only workflow for mapping CMC project work into submission-readiness planning.
- Cover Module 3 gap mapping, vendor dependencies, method/stability dependencies, critical path rules, PM follow-up actions, and human review checklist.
- Preserve that the repository is not an official IND/eCTD submission system, eCTD publisher, GMP/QA record system, or EDMS.

### PR #105 — Project state update after CMC readiness workflow

Updated project-state handoff after PR #104.

### PR #106 — CMC submission readiness mock inventory

Added:

```text
docs/cmc_submission_readiness_mock_inventory.md
```

Purpose:

- Provide a synthetic, non-confidential CMC readiness mock inventory.
- Test whether the workflow can produce a PM-usable Module 3 gap matrix, vendor follow-up list, method/stability dependency map, and critical path summary.
- Keep it documentation-only and avoid storing confidential/GMP/QA/submission records.

Validation recorded for PR #106:

```text
python -m pytest tests/test_readme_documentation_index.py -q → passed
python -m pytest -q → 210 passed
```

### PR #107 — CMC submission readiness input template and prompt pack

Added:

```text
docs/cmc_submission_readiness_input_template.md
```

Also updated:

```text
README.md
tests/test_readme_documentation_index.py
```

Purpose:

- Define a reusable docs/spec-only input template and prompt pack for non-confidential CMC readiness information.
- Support consistent generation of Module 3 gap matrix, vendor follow-up list, method/stability dependency map, decision log, PM next-action list, human review checklist, and management-ready readiness drafting.
- Absorb duplicate README-index wording from PR #108 and PR #109.

Validation recorded for PR #107:

```text
python -m pytest tests/test_readme_documentation_index.py -q → 10 passed in 0.03s
python -m pytest -q → 212 passed in 3.47s
git status --short → clean / no output
```

### PR #108 and PR #109 — Closed duplicate README-index wording PRs

PR #108 and PR #109 only updated the README wording for `docs/cmc_submission_readiness_mock_inventory.md`. That wording was absorbed into PR #107.

Status:

```text
PR #108: closed as superseded, not merged
PR #109: closed as superseded, not merged
```

### PR #110 — Project state sync after CMC readiness input template

Updated:

```text
.ai/PROJECT_STATE.md
PROJECT_STATE_CONTINUATION.md
```

Purpose:

- Synchronize state/handoff after PR #107.
- Record CMC readiness input template completion and duplicate PR handling.
- Preserve `.ai/PROJECT_STATE.md` test-contract fields.

Validation recorded for PR #110:

```text
python -m pytest tests/test_project_state_release_tag_consistency.py -q → 5 passed in 0.03s
python -m pytest tests/test_readme_documentation_index.py -q → 10 passed in 0.02s
python -m pytest -q → 212 passed in 3.37s
git status --short → clean / no output
```

### PR #111 — CMC readiness management summary prompt revision

Updated:

```text
docs/cmc_submission_readiness_input_template.md
```

Purpose:

- Revise Prompt 6 from a brief one-time management summary prompt into a controlled management summary and weekly reporting stress-test prompt.
- Add required fields for report context, one-sentence executive summary, current/prior R/Y/G status, movement reason, top management concerns, critical path movement, decisions needed this week, vendor escalations, completed this week, next-week priorities, items not suitable for management escalation, assumptions/caveats, and template adequacy check.
- Keep the correction inside the existing input template instead of immediately adding `docs/cmc_management_weekly_report_template.md`.

Validation recorded for PR #111:

```text
python -m pytest tests/test_readme_documentation_index.py -q → 10 passed in 0.02s
python -m pytest -q → 212 passed in 2.89s
git status --short → clean / no output
```

### Second Claude Project stress test after PR #111

Result:

```text
Prompt 6 adequacy assessment: PASS
Repository action recommendation: No repo change needed
```

Interpretation:

- Updated Prompt 6 is sufficient for recurring weekly management reporting under the current mock-case stress test.
- No recurring structural gap was found that justifies creating `docs/cmc_management_weekly_report_template.md` at this time.
- Do not create `docs/cmc_management_weekly_report_template.md` unless future repeated stress tests or real non-confidential/de-identified use show a structural gap that cannot reasonably fit in the existing input template.

## Current overall product status

Estimated progress against the user's broader target system:

```text
Overall CMC PM + regulatory-clinical intelligence system: about 62% complete.
MVP regulatory-clinical intelligence prototype: about 70% complete.
CMC readiness docs/spec workflow: usable for non-confidential dry-run, prompt-based assessment, and mock weekly management reporting.
```

What is now working:

- MVP source scope and guardrails are defined.
- FDA / TFDA / ClinicalTrials.gov MVP tools and safety interpretation rules exist.
- Source failure and source limitation wording is controlled.
- Regulatory-clinical digest memo workflow, prompt pack, validation exercise, template contract, and clean-source dry-run exist.
- CMC submission readiness mapping workflow exists as docs/spec-only.
- CMC submission readiness mock inventory exists as docs/spec-only.
- CMC submission readiness input template and prompt pack exist as docs/spec-only.
- Prompt 6 now supports mock management weekly reporting stress-test output.
- README documentation index tests pass after PR #111.

What remains intentionally not implemented:

- Runtime report generator.
- Template renderer.
- MCP-side report generation helper.
- Persistent source-failure event store.
- Dashboard, scheduler, alerting, external integration, or GitHub automation.
- Additional source expansion.
- Official eCTD publishing, EDMS, GMP/QA record, or submission record storage.
- Management decision automation.
- Dedicated `docs/cmc_management_weekly_report_template.md`.

## Current guardrails

- Keep MVP source scope limited to FDA, TFDA, and ClinicalTrials.gov.
- Do not add new agencies, sources, MCP tools, transport modes, dashboards, schedulers, alerts, persistence, external integrations, GitHub automation, or repository automation unless explicitly approved.
- Keep future work small and phase-controlled.
- Use Traditional Chinese for user-facing discussion.
- Avoid accidental Japanese output.
- After repeated related PRs, pause for direction calibration before continuing.
- Repo is not a GMP, QA, EDMS, eCTD publishing, or official system of record.
- Do not store confidential, signed, GMP raw, QA-approved, official submission, vendor confidential, or non-public company records in this repo.
- Due to Codespaces quota limits until July 2026, prefer Claude Code Web and Codex Web for upcoming code/test work. Provide Codespaces commands only as optional fallback or when the user confirms availability.

## Recommended next step

Do not immediately build runtime automation, add another CMC template document, or create `docs/cmc_management_weekly_report_template.md`.

Recommended next action:

```text
Pause for direction calibration. Choose the next workstream deliberately rather than adding more CMC weekly-report documents.
```

Recommended options for direction calibration:

```text
1. Use the current CMC readiness workflow with future non-confidential/de-identified inputs without new repo changes.
2. Return to regulatory-clinical digest workflow refinement only if a concrete recurring PM/RA use case is defined.
3. Consider source expansion only through the documented decision matrix and only after explicit user approval.
4. Consider runtime/report automation only after a separate approval decision covering workflow, fields, limitations, testing, and maintenance scope.
```

## New-chat opening prompt

請根據 GitHub repo `fyz1500wr/pharma-regulatory-clinical-intelligence-mcp`、`.ai/PROJECT_STATE.md`、以及 `PROJECT_STATE_CONTINUATION.md` 繼續。

請用繁體中文回覆，不要輸出日文。

請先確認：

1. `main` 是否已包含 PR #111；
2. `PROJECT_STATE_CONTINUATION.md` 和 `.ai/PROJECT_STATE.md` 是否已記錄 PR #104–#111、PR #111 Prompt 6 revision、第二次 Claude Project stress test PASS、以及不需新增 `docs/cmc_management_weekly_report_template.md`；
3. 是否有 open PR；
4. 最新測試狀態；
5. 後續 code/test 工作是否應優先使用 Claude Code Web / Codex Web，而不是 Codespaces。

目前建議下一步是：

```text
Pause for direction calibration. Choose the next workstream deliberately rather than adding more CMC weekly-report documents.
```

請維持 docs/spec-only，不要新增 runtime generator、MCP tool、source、scheduler、dashboard、alerts、persistence、HTTP/SSE、`.mcp.json`、company alias database、corporate-family mapping、product ownership inference、literature/patent/finance/news integration，除非我明確批准。